Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $1.04 per share versus the Zacks Consensus Estimate of a loss of$0.86. This compares to earnings of $1.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.93$0.78 per share when it actually produced a loss of $0.42, delivering a surprise of +46.15%.Over the last four quarters, the com ...